Alzheimer’s drug being considered by MHRA for UK approval If approved, experts say lecanemab would be the first Alzheimer's disease drug in the UK for nearly 20 years.…
Oxybutynin to remain prescription-only medicine, following MHRA consultation The medicines regulator said "overwhelming responses" to its consultation contributed to its decision against reclassification.…
Medicines regulator issues advice to prevent severe harm from JAK inhibitors The Medicines and Healthcare products Regulatory Agency has advised against prescribing janus kinase inhibitors in patients with certain risk factors.…
Two prescribers must agree that acne is ‘severe enough’ before under-18s are prescribed isotretinoin, review concludes The Commission on Human Medicines' recommendations will be taken forward by the Medicines and Healthcare products Regulatory Agency to support the acne drug's safe use.…
Medicines regulator approves UK’s first dual combination inhaler for mild asthma AstraZeneca said the marketing authorisation meant its Symbicort Turbohaler 200/6 could be used by 2.7 million adults in the UK who live with mild asthma.…
Epilepsy charities call on government to immediately halt two-clinician sign-off for patients taking valproate A coalition of epilepsy charities has said the decision is "totally out of proportion to the risks to patient safety".…
UK is first country to approve bivalent COVID-19 vaccine The Spikevax Bivalent Original/Omicron by Moderna targets both the original strain of SARS-CoV-2 and Omicron variant.…
Safety review launched into anti-epileptic medicine topiramate over fears of harm to unborn children The review was prompted by study results that showed there was a two- to four-fold increased risk of developmental disorders or learning difficulties in children exposed to topiramate before birth.…
MHRA to consider evidence on transgenerational effects of sodium valproate The regulator has asked the Commission on Human Medicines to look at data showing the transgenerational effects of sodium valproate in mice.…
First monoclonal antibody treatment approved for prevention of COVID-19 Evusheld is the first monoclonal antibody treatment to be approved as a 'pre-exposure prophylaxis' treatment.…